Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2012

Nov 13, 2012

32566_dirs_2012-11-13_76523ffa-25ab-4cc5-99da-aacfc23e65ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2012-11-09

Reporting Person: MELDRUM PETER D (Director, President & C.E.O.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-09 Common Stock M 25000 $5.89 Acquired 109225 Direct
2012-11-09 Common Stock S 25000 $29.7117 Disposed 84225 Direct
2012-11-12 Common Stock M 25000 $5.89 Acquired 109225 Direct
2012-11-12 Common Stock S 25000 $29.9135 Disposed 84225 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-11-09 Non-Qualified Stock Option (right to buy) $5.89 M 25000 Disposed 2014-09-08 Common Stock (25000) Direct
2012-11-12 Non-Qualified Stock Option (right to buy) $5.89 M 25000 Disposed 2014-09-08 Common Stock (25000) Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.